Ontonix Obtains Contract from Biotronik

/

Como, October 2-nd 2014. Ontonix announces agreement with Berlin-based Biotronik to evaluate its QCM (Quantitative Complexity Management) technology in the analysis of monitored patients who are undergoing Cardiac Resynchronization Therapy. The objective is to apply QCM in an early-warning context.


About Biotronik

One of the world´s leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by a global workforce of more than 5600 employees. Several million patients have received BIOTRONIK implants designed to save lives and improve quality of life. For more information on Biotronik visit website.

/ /

Dr. Jacek Marczyk

Visionary, ex rocket scientist, businessman and writer with over 35 years of experience in QUANTITATIVE large-scale Uncertainty and Complexity Management in diverse fields (manufacturing, finance, economics).

Author of ten books on simulation, uncertainty and complexity management, rating.

Developed in mid 90s the theory of eigenvalue orbits, a generalization of the concept of eigenvalue.

In 2000-2005 has developed the first Quantitative Complexity Theory (QCT), including a comprehensive measure of complexity.

Founded Ontonix Complexity Management in 2005 in the USA and launched in 2006 the first commercial system for MEASURING and managing complexity: OntoSpace.

www.ontonix.com

In 2009 developed real-time technology to measure the complexity and stability of patients during operation or permanence in Intensive Care Units.

http://www.ontomed.net

Developed a new theory of risk and rating published in 2009 in a book entitled "A New Theory of Risk and Rating".

Over last decade develops quantitative complexity management (QCM) technology and solutions for applications in economics, finance, Risk Rating and Management as well as in Asset Management and medicine. In the past five years works towards the democratization of ratings.